Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and… Read more
Panacea Life Sciences Holdings Inc (PLSH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.388x
Based on the latest financial reports, Panacea Life Sciences Holdings Inc (PLSH) has a cash flow conversion efficiency ratio of -0.388x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.46 Million) by net assets ($3.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Panacea Life Sciences Holdings Inc - Cash Flow Conversion Efficiency Trend (2017–2023)
This chart illustrates how Panacea Life Sciences Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Panacea Life Sciences Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panacea Life Sciences Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ralco Agencies Ltd
TA:RLCO
|
0.187x |
|
Sentoria Group Bhd
KLSE:5213
|
-2.641x |
|
TYSON FOODS -A- - Dusseldorf Stock Exchang
DU:TF7A
|
0.044x |
|
InnoCan Pharma Corporation
OTCQB:INNPF
|
0.002x |
|
Embraer S.A. Reg. Shs
STU:EMY
|
-0.013x |
|
Energy and Water Development Corp
OTCQB:EAWD
|
0.101x |
|
Infrax Systems Inc
PINK:IFXY
|
-81.354x |
|
CAT Strategic Metals Corporation
PINK:CATTF
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Panacea Life Sciences Holdings Inc (2017–2023)
The table below shows the annual cash flow conversion efficiency of Panacea Life Sciences Holdings Inc from 2017 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-8.29 Million | $-1.52 Million | 0.184x | -83.57% |
| 2022-12-31 | $-2.14 Million | $-2.40 Million | 1.119x | +302.62% |
| 2021-12-31 | $7.10 Million | $-3.92 Million | -0.552x | -136.39% |
| 2020-12-31 | $-5.04 Million | $-7.65 Million | 1.518x | +243.68% |
| 2019-12-31 | $3.68 Million | $-3.89 Million | -1.056x | -876.58% |
| 2018-12-31 | $-3.42 Million | $-465.75K | 0.136x | -75.60% |
| 2017-12-31 | $-2.22 Million | $-1.23 Million | 0.557x | -- |